|CBU Currency of 20.11.2018|
|www.cbu.uz||USD = 8277.53|
|EUR = 9451.28|
|RUB = 125.56|
The Agency for Development of Pharmaceutical Industry under the Ministry of Health of Uzbekistan reached agreements on organizing production of Korean high-performance drugs in Uzbekistan.
The agreements were reached within the framework of the state visit of the President of the Republic of Uzbekistan Shavkat Mirziyoyev to the Republic of Korea,
According to the press center for coverage of the state visit of the President of Uzbekistan to the Republic of Korea, the Agency for Development of Pharmaceutical Industry reached agreements with such leading Korean companies as Dalim BioTech, Yuhan Corporation and Erae.
As part of the reached agreements, Korean companies will invest US$25.0 million foreign direct investment into Uzbekistan.
The sides agreed on accelerating implementation of investment projects. Particular attention was paid to the creation in the Republic of Uzbekistan of 7 new pharmaceutical free economic zones.
The Korean companies have assured their firm intention to cooperate and invest in Uzbekistan.
RusHydro will develop projects for the construction of two hydropower plants in Uzbekistan18 October 2018
The President gave instructions on the development of the chemical industry02 October 2018
Indian company is studying the construction of a solar power plant in Uzbekistan Tashkent, Uzbekistan08 September 2018
Ministry of Transport to be created in Uzbekistan08 September 2018
President gives instructions for development of road transport infrastructure07 September 2018
World Bank launches a new phase of the horticulture development project in the regions of Uzbekistan